Pembrolizumab,Olaparib
Astrazeneca,Merck
['polar,(-polari),(-polarg)', 'brca', 'pancreatic', 'pola', 'olaparib', 'pembro', 'brca p']
pembro + olaparib maintenece #polar trial (b&amp;c) in non-brca potential #hrd stage iv #pancreaticcancer n=30. well-tolerated. 30% had no progression for &gt; 6mo without chemo. deep science &amp; polar a #brca awaited. #gratitude &amp; to msk team &amp; patients #asco23 
🗽#NYC 🩺 #GI #oncologist @MSKCancerCenter #PancreaticCancer💜#BiliaryCancer 💚 #science 🧬 #fan #running #26.2 #research #trial #췌장담관암